Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy

about

Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy

Item

http://www.wikidata.org/entity/Q59129603

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Identification of Novel Antise ...... c Treatment of Dysferlinopathy

@en

Identification of Novel Antise ...... c Treatment of Dysferlinopathy

@nl

type

Item

label

Identification of Novel Antise ...... c Treatment of Dysferlinopathy

@en

Identification of Novel Antise ...... c Treatment of Dysferlinopathy

@nl

prefLabel

Identification of Novel Antise ...... c Treatment of Dysferlinopathy

@en

Identification of Novel Antise ...... c Treatment of Dysferlinopathy

@nl

P1476

Identification of Novel Antise ...... c Treatment of Dysferlinopathy

@en

P2093

Hidetoshi Sakurai

http://www.w3.org/2001/XMLSchema#string

Joshua J A Lee

http://www.w3.org/2001/XMLSchema#string

Rika Maruyama

http://www.w3.org/2001/XMLSchema#string

Toshifumi Yokota

http://www.w3.org/2001/XMLSchema#string

P2860

The caveolin proteins

Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains

AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration

Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b

Crystal structures of the human Dysferlin inner DysF domain

Dysferlin is a plasma membrane protein and is expressed early in human development

Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype

Defective membrane repair in dysferlin-deficient muscular dystrophy

Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing

Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype

P304

596-604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTN.2018.10.004

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

William Duddy

P577

2018-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30439648

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

molecular medicine

P932

6234522

http://www.w3.org/2001/XMLSchema#string